Page 20 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg
P. 20
Chapter 1
patients. Pharmacogenomics. 2016;17(7):721-729.
49. Lunenburg CATC, Guchelaar HJ, van Schaik RHN, Neumaier M, Swen JJ. Confirmation practice in
pharmacogenetic testing; how good is good enough? Clin Chim Acta. 2018.
50. Lunenburg CATC, Henricks LM, van Kuilenburg ABP, et al. Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants. Genes. 2018;9(12).
18
